Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Papadia

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Familial Cancer|October 13, 2011
Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in ItalyP Ghiorzo, V Pensotti, G Fornarini, et al.
Journal of Chemotherapy (Florence, Italy)|April 8, 1998
Increased burn patient survival with once-a-day high dose teicoplanin and netilmicin. An Italian multicenter studyL Donati, P Periti, A Andreassi, et al.
Molecular Genetics and Metabolism Reports|July 14, 2017
Home infusion program with enzyme replacement therapy for Fabry disease: The experience of a large Italian collaborative groupD Concolino, L Amico, M D Cappellini, et al.
Journal of Medical Genetics|December 20, 2011
A novel microdeletion syndrome at 3q13.31 characterised by developmental delay, postnatal overgrowth, hypoplastic male genitals, and characteristic facial featuresAnna-Maja Molin, J Andrieux, D A Koolen, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Familial Cancer|October 13, 2011
Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in ItalyP Ghiorzo, V Pensotti, G Fornarini, et al.
Journal of Chemotherapy (Florence, Italy)|April 8, 1998
Increased burn patient survival with once-a-day high dose teicoplanin and netilmicin. An Italian multicenter studyL Donati, P Periti, A Andreassi, et al.
Molecular Genetics and Metabolism Reports|July 14, 2017
Home infusion program with enzyme replacement therapy for Fabry disease: The experience of a large Italian collaborative groupD Concolino, L Amico, M D Cappellini, et al.
Journal of Medical Genetics|December 20, 2011
A novel microdeletion syndrome at 3q13.31 characterised by developmental delay, postnatal overgrowth, hypoplastic male genitals, and characteristic facial featuresAnna-Maja Molin, J Andrieux, D A Koolen, et al.
Pageof 4